EQS-News: GeoVax, Inc.
/ Key word(s): Science
GeoVax Highlights Critical Role of Multi-Antigen COVID-19 Vaccines as Nimbus Variant Underscores Persistent and Evolving Public Health Threat 03.07.2025 / 15:12 CET/CEST
The issuer is solely…Read More
You might also be interested in reading Loblaw Companies Non-GAAP EPS of C$2.20, revenue of C$14.95B; initiates FY25 outlook.